Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
48M
-
Number of holders
-
129
-
Total 13F shares, excl. options
-
25.4M
-
Shares change
-
+1.36M
-
Total reported value, excl. options
-
$915M
-
Value change
-
+$45.1M
-
Put/Call ratio
-
0.44
-
Number of buys
-
62
-
Number of sells
-
-62
-
Price
-
$36.00
Significant Holders of BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) as of Q1 2021
160 filings reported holding BLFS - BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share as of Q1 2021.
BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) has 129 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.4M shares
of 48M outstanding shares and own 52.9% of the company stock.
Largest 10 shareholders include Casdin Capital, LLC (7.44M shares), VANGUARD GROUP INC (1.41M shares), BlackRock Inc. (1.31M shares), MARSHALL WACE, LLP (1.18M shares), WASATCH ADVISORS INC (1.13M shares), GENEVA CAPITAL MANAGEMENT LLC (1.03M shares), Ranger Investment Management, L.P. (923K shares), AMERIPRISE FINANCIAL INC (918K shares), Russell Investments Group, Ltd. (651K shares), and BANK OF AMERICA CORP /DE/ (527K shares).
This table shows the top 129 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.